Cardiovascular disease: risk assessment and reduction, including lipid modification

and the committee's discussion are in evidence review A: CVD risk assessment tools: primary prevention. 1.2 Aspirin for primary prevention of cardiovascular disease 1.2.1 Do not routinely offer aspirin for primary prevention of CVD. [January 2023] For guidance on using aspirin to prevent venous thromboembolism in over 16s in hospital, see NICE's guideline on venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE's surveillance team reviewed the evidence about aspirin for the primary prevention of CVD. Based on the review, NICE decided to add a do not routinely offer recommendation about this. For full details, see the January 2023 exceptional surveillance report. 1.3 Lifestyle changes for the primary and secondary prevention of cardiovascular disease Behaviour change 1.3.1 Advise and support people at high risk of or with CVD to achieve a healthy lifestyle in line with NICE's guideline on behaviour change: general approaches. [2014, amended May 2023] Healthy eating For advice on healthy eating, see the NHS eat well guide. Cardioprotective diet 1.3.2 Advise people at high risk of or with CVD to eat a diet in which total fat intake is 30% or less of total energy intake, saturated fats are
